Migdal Insurance & Financial Holdings’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-511	Closed	-$32K	–	762
2018 Q1	$32K	Hold	511	–	–	﹤0.01%	472
2017 Q4	$33K	Sell	511 -70	-12%	-$4.49K	﹤0.01%	441
2017 Q3	$38K	Sell	581 -4,200	-88%	-$265K	﹤0.01%	464
2017 Q2	$300K	Sell	4,781 -665	-12%	-$39.9K	0.01%	255
2017 Q1	$320K	Sell	5,446 -20	-0.4%	-$1.17K	0.01%	278
2016 Q4	$306K	Buy	+5,466	New	+$315K	0.01%	232

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Migdal Insurance & Financial Holdings's PJP Position: Q2 2018 in Review

Migdal Insurance & Financial Holdings sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 511 shares — an estimated $32K sold.

Migdal Insurance & Financial Holdings first reported a position in PJP in Q4 2016 and held it in 6 quarters. The position peaked at $320K in Q1 2017. 85 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

Migdal Insurance & Financial Holdings reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 511 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $32K.
Migdal Insurance & Financial Holdings first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 6 quarters.
Migdal Insurance & Financial Holdings's Invesco Pharmaceuticals ETF position peaked at $320K in Q1 2017.
85 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2018, filed 1 Aug 2018.